RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.38−0.01 (-1.60%)
Close on Nov 13, 2026Market cap $1.91MP/E –Yield –
RedHill Biopharma operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -2776.9%, against -80.5% the year before. The highest annual figure on record is -69.3% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2776.9% | −2696.4 |
| FY2024 | Dec 31, 2024 | -80.5% | +65.7 |
| FY2023 | Dec 31, 2023 | -146.2% | −76.9 |
| FY2022 | Dec 31, 2022 | -69.3% | +25.3 |
| FY2021 | Dec 31, 2021 | -94.6% | +4.3 |
| FY2020 | Dec 31, 2020 | -99.0% | +587.8 |
| FY2019 | Dec 31, 2019 | -686.7% | −216.2 |
| FY2018 | Dec 31, 2018 | -470.5% | +826.6 |
| FY2017 | Dec 31, 2017 | -1297.0% | +28943.6 |
| FY2016 | Dec 31, 2016 | -30240.6% | +703159.4 |
| FY2015 | Dec 31, 2015 | -733400.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -49.9% | +356.8 |
| Q2 FY2021 | Jun 30, 2021 | -115.7% | +2687.4 |
| Q2 FY2020 | Jun 30, 2020 | -59.8% | – |
| Q2 FY2019 | Jun 30, 2019 | -792.1% | – |
| Q2 FY2018 | Jun 30, 2018 | -406.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -2803.1% | – |
See a number that looks wrong?